Patents by Inventor Ira SAVETSKY

Ira SAVETSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treatment of edema
    Patent number: 12144805
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-?1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Grant
    Filed: January 27, 2023
    Date of Patent: November 19, 2024
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Babak Mehrara, Jason Gardenier, Ira Savetsky, Omer Aras
  • Compositions and Methods for Treatment of Edema
    Publication number: 20230241043
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-?1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Application
    Filed: January 27, 2023
    Publication date: August 3, 2023
    Inventors: Babak MEHRARA, Jason GARDENIER, Ira SAVETSKY, Omer ARAS
  • Compositions and methods for treatment of edema
    Patent number: 11583523
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-?1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: February 21, 2023
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Babak Mehrara, Jason Gardenier, Ira Savetsky, Omer Aras
  • Compositions and Methods for Treatment of Edema
    Publication number: 20210069164
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-?1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 11, 2021
    Inventors: Babak MEHRARA, Jason GARDENIER, Ira SAVETSKY, Omer ARAS
  • Compositions and methods for treatment of edema
    Patent number: 10874651
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-?1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: December 29, 2020
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Babak Mehrara, Jason Gardenier, Ira Savetsky, Omer Aras
  • Compositions and Methods for Treatment of Edema
    Publication number: 20200016137
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-?1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Application
    Filed: February 15, 2019
    Publication date: January 16, 2020
    Inventors: Babak MEHRARA, Jason GARDENIER, Ira SAVETSKY, Omer ARAS
  • Compositions and methods for treatment of edema
    Patent number: 10251871
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-?1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: April 9, 2019
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Babak Mehrara, Jason Gardenier, Ira Savetsky, Omer Aras
  • Compositions and Methods for Treatment of Edema
    Publication number: 20180028514
    Abstract: Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-? agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.
    Type: Application
    Filed: February 5, 2016
    Publication date: February 1, 2018
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Babak Mehrara, Jason GARDENIER, Ira SAVETSKY, Omer ARAS